Our regulatory
affairs team has up to date knowledge of regional as well as
global regulatory requirements. We offer competitive product
clinical development plans, rapid study startup and effective
submissions strategies. Our regulatory professionals have broad
therapeutic expertise and experience. This is feasible through
close alliance with multi-functional project teams that support
early clinical trial development and late phase trials. Our
team of Regulatory Affairs experts plays a key role in your
clinical project from initiation to completion of the project,
ensuring compliance with applicable laws and regulations
throughout the process. Our staff has vast experience and
knowledge to support client needs throughout the entire product
lifecycle, from defining the regulatory development strategy, to
clinical trial and marketing authorization submissions, through to
post-licensing support.
A well-designed regulatory
submission meets the information needs of all relevant
stakeholders. Clintrac consulting professionals can aid you in
devising a plan to collect the data needed to support your
endpoints, while enabling you to meet both your business
objectives and your compulsion to the safety of study
participants. Clintrac's contribution to projects can range from
the strategic planning of critical paths to applying for clinical
trial and marketing authorizations.
Our services include:
|

|
Preparation
and submission of IND application.
|
|

|
Preparation
and submission of ANDA.
|
|

|
Drug
development strategy.
|
|

|
Orphan drug
applications.
|
|

|
Marketing
Authorization Applications (MAA).
|
|

|
Pediatric
Investigational Plan (PIP) .
|
|

|
Facilitation
of the review process.
|
|

|
Safety
reporting.
|
|

|
NOC for
export of biological samples for testing.
|
|

|
Regulatory
approvals for conducting BA/BE clinical studies.
|
|

|
Assessment
and evaluation of dossiers for regulatory submission.
|
|